Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Hongchen Hua"'
Autor:
Ying Jiang, Xuemei Zhang, Hongjie Mu, Hongchen Hua, Dongyu Duan, Xiuju Yan, Yiyun Wang, Qingqing Meng, Xiaoyan Lu, Aiping Wang, Wanhui Liu, Youxin Li, Kaoxiang Sun
Publikováno v:
Drug Delivery, Vol 25, Iss 1, Pp 143-152 (2018)
A microsphere–gel in situ forming implant (MS–Gel ISFI) dual-controlled drug delivery system was applied to a high water-soluble small-molecule compound Rasagiline mesylate (RM) for effective treatment of Parkinson’s disease. This injectable co
Externí odkaz:
https://doaj.org/article/63bffde498054c508b9ff68888de9403
Autor:
Hongjie Mu, Yiyun Wang, Yongchao Chu, Ying Jiang, Hongchen Hua, Liuxiang Chu, Kaili Wang, Aiping Wang, Wanhui Liu, Youxin Li, Fenghua Fu, Kaoxiang Sun
Publikováno v:
Drug Delivery, Vol 25, Iss 1, Pp 1372-1383 (2018)
Bevacizumab is an anti-vascular endothelial growth factor drug that can be used to treat choroidal neovascularization (CNV). Bevacizumab-loaded multivesicular liposomes (Bev-MVLs) have been designed and developed to increase the intravitreal retentio
Externí odkaz:
https://doaj.org/article/dceff8ba67254f029ba91f21f1ea234d
Autor:
Wanhui Liu, Ying Jiang, Kaili Wang, Yongchao Chu, Hongchen Hua, Liuxiang Chu, Yiyun Wang, Hongjie Mu, Kaoxiang Sun, Youxin Li, Fenghua Fu, Aiping Wang
Publikováno v:
Drug Delivery
Drug Delivery, Vol 25, Iss 1, Pp 1372-1383 (2018)
Drug Delivery, Vol 25, Iss 1, Pp 1372-1383 (2018)
Bevacizumab is an anti-vascular endothelial growth factor drug that can be used to treat choroidal neovascularization (CNV). Bevacizumab-loaded multivesicular liposomes (Bev-MVLs) have been designed and developed to increase the intravitreal retentio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2434bcf27429a524878939678f2244f5
http://europepmc.org/articles/PMC6058521
http://europepmc.org/articles/PMC6058521
Autor:
Yaping Zhang, Hongjie Mu, Sha Liu, Kaoxiang Sun, Hongchen Hua, Xuemei Zhang, Zhihui Wan, Aiping Wang, Ying Jiang, Qingqing Meng, Yiyun Wang, Xiaoyan Lu
Publikováno v:
International Journal of Pharmaceutics. 543:179-189
Gliomas are the most common malignant brain tumor, but treatment is limited by the blood–brain barrier (BBB), especially for chemotherapeutic drugs. Although some chemotherapy drugs can pass through the BBB, many of these agents are toxic to normal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b351b39796c338d1ae824c6bd8a8a4a
https://doi.org/10.1016/j.ijpharm.2018.03.028
https://doi.org/10.1016/j.ijpharm.2018.03.028
Autor:
Hongchen Hua, Yiyun Wang, Qingqing Meng, Hongjie Mu, Zimei Wu, Kaoxiang Sun, Ying Jiang, Aiping Wang
Publikováno v:
International Journal of Nanomedicine
Qingqing Meng,1,* Aiping Wang,1,2,* Hongchen Hua,1 Ying Jiang,1 Yiyun Wang,1 Hongjie Mu,1 Zimei Wu,1 Kaoxiang Sun1 1School of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Ya
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aad36203a53f92a3e21c82356f7a6940
https://doi.org/10.2147/ijn.s151474
https://doi.org/10.2147/ijn.s151474
Autor:
Hongchen Hua, Yanan Shi, Youxin Li, Xuejuan Li, Xuemei Zhang, Wanhui Liu, Kaoxiang Sun, Fenghua Fu, Aiping Wang
Publikováno v:
International Journal of Nanomedicine
Xuemei Zhang,1–3 Xuejuan Li,1,4 Hongchen Hua,1 Aiping Wang,1 Wanhui Liu,1–3 Youxin Li,1–3 Fenghua Fu,1–3 Yanan Shi,5 Kaoxiang Sun1 1School of Pharmacy, Yantai University, Yantai, Shandong Province, People’s Republic of China; 2State Key Lab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80fa5fba97ca639162fc1fc78de798de
https://doi.org/10.2147/ijn.s138501
https://doi.org/10.2147/ijn.s138501
Autor:
Bin He, Kaoxiang Sun, Aiping Wang, Hongchen Hua, Yongchao Chu, Huajun Yu, Ning Chen, Hongjie Mu
Publikováno v:
International Journal of Nanomedicine
Yongchao Chu,1,* Ning Chen,2,* Huajun Yu,2,* Hongjie Mu,1 Bin He,1 Hongchen Hua,1 Aiping Wang,1 Kaoxiang Sun1 1School of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Key Lab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a70c6879bc521873afd50dcd65c243f
https://pubmed.ncbi.nlm.nih.gov/28260884
https://pubmed.ncbi.nlm.nih.gov/28260884
Autor:
Youxin Li, Kaoxiang Sun, Xiuju Yan, Hongjie Mu, Dongyu Duan, Hongchen Hua, Aiping Wang, Ying Jiang, Wanhui Liu, Xuemei Zhang, Yiyun Wang, Xiaoyan Lu, Qingqing Meng
Publikováno v:
Drug Delivery
Drug Delivery, Vol 25, Iss 1, Pp 143-152 (2018)
Drug Delivery, Vol 25, Iss 1, Pp 143-152 (2018)
A microsphere–gel in situ forming implant (MS–Gel ISFI) dual-controlled drug delivery system was applied to a high water-soluble small-molecule compound Rasagiline mesylate (RM) for effective treatment of Parkinson’s disease. This injectable co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5645a3ebcc0e17aab5d892d6bc64ec7e
Autor:
Xuemei Zhang, Xuejuan Li, Hongchen Hua, Aiping Wang, Wanhui Liu, Youxin Li, Fenghua Fu, Yanan Shi, Kaoxiang Sun
Publikováno v:
International Journal of Nanomedicine; Aug2017, Vol. 12, p5717-5732, 16p
Autor:
Yongchao Chu, Ning Chen, Huajun Yu, Hongjie Mu, Bin He, Hongchen Hua, Aiping Wang, Kaoxiang Sun
Publikováno v:
International Journal of Nanomedicine; Feb2017, Vol. 12, p1353-1368, 16p